Biochemical and Structural Insights into 6-phosphogluconate Dehydrogenase from Leishmania Donovani

Overview

Journal Appl Microbiol Biotechnol

Specialties Biomedical Engineering
Biotechnology
Microbiology

Date 2021 Jul 12

PMID 34250571

Citations 8

Authors

Pranay Jakkula

Bandigi Narsimulu

Insaf Ahmed Qureshi

Affiliations

Soon will be listed here.

Abstract

6-phosphogluconate dehydrogenase (6PGDH) participates in pentose phosphate pathway of glucose metabolism by catalyzing oxidative decarboxylation of 6-phsophogluconate (6PG) and its absence has been lethal for several eukaryotes. Despite being a validated drug target in many organisms like Plasmodium, the enzyme has not been explored in leishmanial parasites. In the present study, 6PGDH of Leishmania donovani (Ld6PGDH) is cloned and purified followed by its characterization using biochemical and structural approaches. Ld6PGDH lacks the glycine-serine-rich sequence at its C-terminal that is present in other eukaryotes including humans. Leishmanial 6PGDH possesses more affinity for substrate (6PG) and cofactor (NADP) in comparison to that of human. The enzymatic activity is inhibited by gentamicin and cefuroxime through competitive mode with functioning more potently towards leishmanial 6PGDH than its human counterpart. CD analysis has shown higher α-helical content in the secondary structure of Ld6PGDH, while fluorescence studies revealed that tryptophan residues are not completely accessible to solvent environment. The three-dimensional structure was generated through homology modelling and docked with substrate and cofactor. The docking studies demonstrated two separate binding pockets for 6PG and NADP with higher affinity for the cofactor binding, and Asn105 is interacting with substrate as well as the cofactor. Additionally, MD simulation has shown complexes of Ld6PGDH with 6PG and NADP to be more stable than its apo form. Altogether, the present study might provide the foundation to investigate this enzyme as potential target against leishmaniasis. KEY POINTS: • Ld6PGDH enzymatic activity is competitively inhibited by gentamicin and cefuroxime. • It displays more helical contents and all structural characteristics of 6PGDH family. • Interaction studies demonstrate higher affinity of cofactor than substrate for Ld6PGDH.

Citing Articles

Enzymatic characterization of a thermostable 6-phosphogluconate dehydrogenase from and its application for NADH regeneration.

Feng X, Cui X, Wang K, Liu J, Meng D 3 Biotech. 2024; 15(1):3.

PMID: 39650808 PMC: 11621248. DOI: 10.1007/s13205-024-04165-6.

An integrated multi-omics analysis identifies novel regulators of circadian rhythm and sleep disruptions under unique light environment in Antarctica.

Liu S, Wang J, Tian X, Zhang Z, Wang L, Xiong Y Mol Psychiatry. 2024; .

PMID: 39587296 DOI: 10.1038/s41380-024-02844-7.

Insights into the nutritional value of honeybee drone larvae (Apis mellifera) through proteomic profiling.

Matuszewska-Mach E, Packi K, Rzetecka N, Wielinski W, Kokot Z, Kowalczyk D Sci Rep. 2024; 14(1):28562.

PMID: 39557895 PMC: 11574269. DOI: 10.1038/s41598-024-79479-9.

The Application of MD Simulation to Lead Identification, Vaccine Design, and Structural Studies in Combat against Leishmaniasis - A Review.

Vijayakumar S, Laxman Kumar L, Borkotoky S, Murali A Mini Rev Med Chem. 2023; 24(11):1089-1111.

PMID: 37680156 DOI: 10.2174/1389557523666230901105231.

Metabolomics analysis of visceral leishmaniasis based on urine of golden hamsters.

Yuan D, Chen J, Zhao Z, Qin H Parasit Vectors. 2023; 16(1):304.

PMID: 37649093 PMC: 10469881. DOI: 10.1186/s13071-023-05881-3.

References

Adams M, Ellis G, Gover S, Naylor C, Phillips C . Crystallographic study of coenzyme, coenzyme analogue and substrate binding in 6-phosphogluconate dehydrogenase: implications for NADP specificity and the enzyme mechanism. Structure. 1994; 2(7):651-68. DOI: 10.1016/s0969-2126(00)00066-6. View

Adem S, Ciftci M . Purification and biochemical characterization of glucose 6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase and glutathione reductase from rat lung and inhibition effects of some antibiotics. J Enzyme Inhib Med Chem. 2016; 31(6):1342-8. DOI: 10.3109/14756366.2015.1132711. View

Akyuz M, Erat M, Ciftci M, Gumustekin K, Bakan N . Effects of some antibiotics on human erythrocyte 6-phosphogluconate dehydrogenase: an in vitro and in vivo study. J Enzyme Inhib Med Chem. 2004; 19(4):361-5. DOI: 10.1080/14756360409162451. View

Allmann S, Morand P, Ebikeme C, Gales L, Biran M, Hubert J . Cytosolic NADPH homeostasis in glucose-starved procyclic Trypanosoma brucei relies on malic enzyme and the pentose phosphate pathway fed by gluconeogenic flux. J Biol Chem. 2013; 288(25):18494-505. PMC: 3689991. DOI: 10.1074/jbc.M113.462978. View

Andreini C, Bertini I, Cavallaro G, Holliday G, Thornton J . Metal ions in biological catalysis: from enzyme databases to general principles. J Biol Inorg Chem. 2008; 13(8):1205-18. DOI: 10.1007/s00775-008-0404-5. View

Are S, Gatreddi S, Jakkula P, Qureshi I . Structural attributes and substrate specificity of pyridoxal kinase from Leishmania donovani. Int J Biol Macromol. 2020; 152:812-827. DOI: 10.1016/j.ijbiomac.2020.02.257. View

Barrett M . The pentose phosphate pathway and parasitic protozoa. Parasitol Today. 1997; 13(1):11-6. DOI: 10.1016/s0169-4758(96)10075-2. View

Bhat S, Jagruthi P, Srinivas A, Arifuddin M, Qureshi I . Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1. Eur J Med Chem. 2019; 186:111860. DOI: 10.1016/j.ejmech.2019.111860. View

Cameron S, Martini V, Iulek J, Hunter W . Geobacillus stearothermophilus 6-phosphogluconate dehydrogenase complexed with 6-phosphogluconate. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009; 65(Pt 5):450-4. PMC: 2675582. DOI: 10.1107/S1744309109012767. View

10.

Chen Y, Ko T, Chen W, Lo L, Lin C, Wang A . Conformational changes associated with cofactor/substrate binding of 6-phosphogluconate dehydrogenase from Escherichia coli and Klebsiella pneumoniae: Implications for enzyme mechanism. J Struct Biol. 2009; 169(1):25-35. DOI: 10.1016/j.jsb.2009.08.006. View

11.

Chen H, Zhu Z, Huang R, Zhang Y . Coenzyme Engineering of a Hyperthermophilic 6-Phosphogluconate Dehydrogenase from NADP to NAD with Its Application to Biobatteries. Sci Rep. 2016; 6:36311. PMC: 5090862. DOI: 10.1038/srep36311. View

12.

Corpas F, Barroso J, Aranda F, Lupianez J . Kinetic properties of hexose-monophosphate dehydrogenases. II. Isolation and partial purification of 6-phosphogluconate dehydrogenase from rat liver and kidney cortex. Mol Cell Biochem. 1995; 144(2):97-104. DOI: 10.1007/BF00944387. View

13.

Cronin C, Nolan D, Voorheis H . The enzymes of the classical pentose phosphate pathway display differential activities in procyclic and bloodstream forms of Trypanosoma brucei. FEBS Lett. 1989; 244(1):26-30. DOI: 10.1016/0014-5793(89)81154-8. View

14.

Dyson J, DOrazio R, Hanson W . Sheep liver 6-phosphogluconate dehydrogenase: isolation procedure and effect of pH, ionic strength, and metal ions on the kinetic parameters. Arch Biochem Biophys. 1973; 154(2):623-35. DOI: 10.1016/0003-9861(73)90017-9. View

15.

Esteve M, Cazzulo J . The 6-phosphogluconate dehydrogenase from Trypanosoma cruzi: the absence of two inter-subunit salt bridges as a reason for enzyme instability. Mol Biochem Parasitol. 2003; 133(2):197-207. DOI: 10.1016/j.molbiopara.2003.10.007. View

16.

Gatreddi S, Are S, Qureshi I . Ribokinase from Leishmania donovani: purification, characterization and X-ray crystallographic analysis. Acta Crystallogr F Struct Biol Commun. 2018; 74(Pt 2):99-104. PMC: 5947680. DOI: 10.1107/S2053230X18000109. View

17.

Gonzalez D, Perez J, Serrano M, Igoillo-Esteve M, Cazzulo J, Barrett M . The 6-phosphogluconate dehydrogenase of Leishmania (Leishmania) mexicana: gene characterization and protein structure prediction. J Mol Microbiol Biotechnol. 2010; 19(4):213-23. DOI: 10.1159/000320697. View

18.

Haeussler K, Fritz-Wolf K, Reichmann M, Rahlfs S, Becker K . Characterization of Plasmodium falciparum 6-Phosphogluconate Dehydrogenase as an Antimalarial Drug Target. J Mol Biol. 2018; 430(21):4049-4067. DOI: 10.1016/j.jmb.2018.07.030. View

19.

Hanau S, Rippa M, Bertelli M, Dallocchio F, Barrett M . 6-Phosphogluconate dehydrogenase from Trypanosoma brucei. Kinetic analysis and inhibition by trypanocidal drugs. Eur J Biochem. 1996; 240(3):592-9. DOI: 10.1111/j.1432-1033.1996.0592h.x. View

20.

Hanau S, Rinaldi E, Dallocchio F, Gilbert I, Dardonville C, Adams M . 6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomes. Curr Med Chem. 2004; 11(19):2639-50. DOI: 10.2174/0929867043364441. View